Do point-of-care tests (POCTs) offer a new paradigm for the management of patients with influenza?
- PMID: 33153522
- PMCID: PMC7645971
- DOI: 10.2807/1560-7917.ES.2020.25.44.1900420
Do point-of-care tests (POCTs) offer a new paradigm for the management of patients with influenza?
Abstract
The introduction of point-of-care tests (POCTs) has presented new opportunities for the management of patients presenting to healthcare providers with acute respiratory symptoms. This Perspective article is based on the experiences of national infection teams/those managing acute respiratory infections across the United Kingdom in terms of the challenges and opportunities that this may present for public health. This Perspective article was conceived and written pre-coronavirus disease (COVID-19), however the principles we outline here for influenza can also be translated to COVID-19 and some key points are made throughout the article. The greatest challenge for intergrating POCTs into non-traditional environments is the capture of data and samples for surveillance purposes which provides information for public health action. However, POCTs together with measures outlined in this article, offer a new paradigm for the management and public health surveillance of patients with influenza.
Keywords: Influenza; challenges; opportunities; patient management; point of care testing.
Conflict of interest statement
Similar articles
-
Emerging point of care tests for influenza: innovation or status quo.Influenza Other Respir Viruses. 2012 Jul;6(4):291-8. doi: 10.1111/j.1750-2659.2011.00306.x. Epub 2011 Nov 22. Influenza Other Respir Viruses. 2012. PMID: 22103966 Free PMC article.
-
The potential of diagnostic point-of-care tests (POCTs) for infectious and zoonotic animal diseases in developing countries: Technical, regulatory and sociocultural considerations.Transbound Emerg Dis. 2021 Jul;68(4):1835-1849. doi: 10.1111/tbed.13880. Epub 2020 Oct 30. Transbound Emerg Dis. 2021. PMID: 33058533 Free PMC article. Review.
-
Exploring the barriers and facilitators to use of point of care tests in family medicine clinics in the United States.BMC Fam Pract. 2016 Nov 3;17(1):149. doi: 10.1186/s12875-016-0549-1. BMC Fam Pract. 2016. PMID: 27809865 Free PMC article.
-
The experience of point-of-care testing for influenza in Scotland in 2017/18 and 2018/19 - no gain without pain.Euro Surveill. 2020 Nov;25(44):1900419. doi: 10.2807/1560-7917.ES.2020.25.44.1900419. Euro Surveill. 2020. PMID: 33153519 Free PMC article.
-
The Clinical Utility of Point-of-Care Tests for Influenza in Ambulatory Care: A Systematic Review and Meta-analysis.Clin Infect Dis. 2019 Jun 18;69(1):24-33. doi: 10.1093/cid/ciy837. Clin Infect Dis. 2019. PMID: 30285232 Free PMC article.
Cited by
-
Primary care during COVID-19 pandemic - a survey to establish clinical needs and lessons learned in infectious respiratory diseases in Spain.BMC Prim Care. 2023 Oct 3;24(1):202. doi: 10.1186/s12875-023-02160-z. BMC Prim Care. 2023. PMID: 37789255 Free PMC article.
-
Brand-specific estimates of influenza vaccine effectiveness for the 2021-2022 season in Europe: results from the DRIVE multi-stakeholder study platform.Front Public Health. 2023 Jul 20;11:1195409. doi: 10.3389/fpubh.2023.1195409. eCollection 2023. Front Public Health. 2023. PMID: 37546295 Free PMC article.
-
Emergence of circulating influenza A H3N2 viruses with genetic drift in the matrix gene: be alert of false-negative test results.APMIS. 2022 Oct;130(10):612-617. doi: 10.1111/apm.13262. Epub 2022 Aug 10. APMIS. 2022. PMID: 35836366 Free PMC article.
-
Spotlight influenza: Influenza surveillance before and after the introduction of point-of-care testing in Denmark, season 2014/15 to 2018/19.Euro Surveill. 2021 Sep;26(37):2000724. doi: 10.2807/1560-7917.ES.2021.26.37.2000724. Euro Surveill. 2021. PMID: 34533117 Free PMC article.
-
Rapid influenza molecular testing in secondary care and influenza surveillance in England: Any impact?Influenza Other Respir Viruses. 2022 Sep;16(5):937-941. doi: 10.1111/irv.13001. Epub 2022 May 18. Influenza Other Respir Viruses. 2022. PMID: 35585686 Free PMC article.
References
-
- Public Health England (PHE). Point of care tests for influenza and other respiratory viruses. London: PHE; 27 Nov 2018. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploa...
-
- Merckx J, Wali R, Schiller I, Caya C, Gore GC, Chartrand C, et al. Diagnostic Accuracy of Novel and Traditional Rapid Tests for Influenza Infection Compared With Reverse Transcriptase Polymerase Chain Reaction: A Systematic Review and Meta-analysis. Ann Intern Med. 2017;167(6):394-409. 10.7326/M17-0848 - DOI - PubMed
-
- Youngs J, Marshall B, Farragher M, Whitney L, Glass S, Pope C, et al. Implementation of influenza point-of-care testing and patient cohorting during a high-incidence season: a retrospective analysis of impact on infection prevention and control and clinical outcomes. J Hosp Infect. 2019;101(3):276-84. 10.1016/j.jhin.2018.11.010 - DOI - PubMed
-
- Brendish NJ, Malachira AK, Beard KR, Ewings S, Clark TW. Impact of turnaround time on outcome with point-of-care testing for respiratory viruses: a post hoc analysis from a randomised controlled trial. Eur Respir J. 2018;521800555. 13993003.00555-2018 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical